For citations:

Cabanillas M.E., Takahashi S. Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer. Head and Neck Tumors (HNT). 2019;9(4):49-61. (In Russ.) https://doi.org/10.17650/2222-1468-2019-9-4-49-61